It is currently Mon Sep 15, 2014 2:34 am

News News of Aubagio (teriflunomide)

Site map of Aubagio (teriflunomide) » Forum : Aubagio (teriflunomide)

Aubagio is an oral treatment approved for MS.

Aubagio® study confirms significant disability impact

Image

Genzyme, a Sanofi company announced today that key data from the TOWER trial were presented at the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS). In the study, once-daily, oral Aubagio® 14 mg significantly reduced the annualized relapse rate and slowed progression of disability in patients with relapsing forms of multiple sclerosis (MS) compared to placebo. In addition, the proportion of patients treated with Aubagio who were relapse-free ...
Read more : Aubagio® study confirms significant disability impact | Views : 1672 | Replies : 0


RE FDA NEWS RELEASE ON NEW DRUG AUBAGIO

http://www.fda.gov/NewsEvents/Newsroom/ ... 319277.htm Please read the nwes release by USFDA on the newdrug aubogio
regards
seeva
Read more : RE FDA NEWS RELEASE ON NEW DRUG AUBAGIO | Views : 2847 | Replies : 0


Oral multiple sclerosis pill Aubagio® gets U.S. approval

Image

Sanofi SA has won U.S. approval for its multiple sclerosis pill Aubagio - one of the two treatments for the chronic disease that could return the French drugmaker to growth after several blockbuster drugs lost patent protection.

The drug has been shown to be less effective than some rivals but has milder side effects and analysts say it could find favour among newly diagnosed patients. Around 35 percent to 40 percent of multiple sclerosis ...
Read more : Oral multiple sclerosis pill Aubagio® gets U.S. approval | Views : 5533 | Replies : 2


Aubagio MS drug by Sanofi

Aubagio, MS drug by Sanofi, is new to me:

http://www.reuters.com/article/2012/06/ ... 8820120601

Positive test boosts Sanofi MS drug hopes
Fri, Jun 1 2012
By Christian Plumb and Elena Berton

PARIS (Reuters) - Sanofi reported positive results from a late-stage trial of its Aubagio multiple sclerosis drug, bolstering its chances of approval by regulators as it seeks to catch up with a fast-selling oral treatment from rival Novartis.

Sanofi said ...
Read more : Aubagio MS drug by Sanofi | Views : 4709 | Replies : 3


Sanofi is looking at new compounds to expand MS business

Image

Sanofi, which bought Genzyme Corp. last year, is seeking new treatments to expand its multiple sclerosis business, said Michael Panzara, Genzyme’s therapeutic area head for multiple sclerosis, immune diseases and neurology.

The drugmaker said today its experimental medicine Lemtrada, which it gained through Genzyme, led to an improvement in disability scores in patients suffering from multiple sclerosis compared with an older treatment in a late-stage trial. The company has another experimental MS therapy, Aubagio, ...
Read more : Sanofi is looking at new compounds to expand MS business | Views : 1627 | Replies : 0


EMA accepts oral MS treatment Teriflunomide marketing app.

EMA accepts oral MS treatment Teriflunomide marketing application

Image

Genzyme, a Sanofi company , announced today the European Medicines Agency (EMA) has accepted the filing of the marketing authorization application (MAA) for once-daily oral teriflunomide for the treatment of relapsing forms of multiple sclerosis (MS). Acceptance of the MAA starts the EMA's review process.

"The filing represents another important milestone for teriflunomide and brings us one step closer to offering a new treatment option to ...
Read more : EMA accepts oral MS treatment Teriflunomide marketing app. | Views : 3501 | Replies : 0


Oral Teriflunomide in relapsing MS study reported

Image

Genzyme, a Sanofi company , today reported top-line results from TENERE, a Phase III clinical trial comparing the effectiveness, safety and tolerability of once-daily oral teriflunomide to interferon beta-1a (Rebif(R)), an approved injectable therapy, in people with relapsing forms of multiple sclerosis (RMS).

The TENERE trial, which included 324 patients, is the second completed study of five efficacy studies of teriflunomide in MS, making the clinical program one of the largest and broadest of ...
Read more : Oral Teriflunomide in relapsing MS study reported | Views : 2097 | Replies : 1


Oral Teriflunomide study shows lasting efficacy and safety

Image

The investigational oral drug teriflunomide (Aubagio) seems to have maintained its effectiveness during up to nine years of follow-up in clinical trial patients with the relapsing form of multiple sclerosis, and no late safety problems have been noticed, researchers said here.

The findings came from open-label extensions of phase II and III studies with teriflunomide, which is now under FDA review as a treatment for relapsing-remitting MS. The results were presented in a series ...
Read more : Oral Teriflunomide study shows lasting efficacy and safety | Views : 1681 | Replies : 0


Teriflunomide (Aubagio™*) significantly reduces relapses

Image

Sanofi and its subsidiary Genzyme announced today new data from the pivotal TEriflunomide Multiple Sclerosis Oral (TEMSO) Phase III trial showing that once-daily oral teriflunomide significantly reduced annualized rates of relapses leading to hospitalization. New data also confirmed the safety profile and efficacy of teriflunomide over a six-year period after the initial randomization.

A total of fifteen presentations on teriflunomide are on the program for the fifth joint triennial congress of the European and ...
Read more : Teriflunomide (Aubagio™*) significantly reduces relapses | Views : 1754 | Replies : 0


New oral MS drug may reduce relapses in MS patients

Image

People with multiple sclerosis (MS) may soon have a second needle-free option to control their disease.

Last year, the FDA approved the first disease-modifying pill, a drug called Gilenya, to treat MS.

Now a new study shows that a different drug, a once-daily pill called teriflunomide, may also slow the progression of the neurological disease and its disabling attacks better than a placebo.

Currently, most of the disease-modifying drugs that treat MS are given ...
Read more : New oral MS drug may reduce relapses in MS patients | Views : 1622 | Replies : 3


 

Login  •  Register


Statistics

Total posts 219929 • Total topics 22739 • Total members 14342


Contact us | Terms of Service